Impact of variable fee schedule reimbursement (VFSR) on anti-emetic utilization and quality of care.

e18256Background: Due to current payment models, reimbursement for 5-HT3 receptor antagonists (5-HT3-i’s) is largely driven by drug acquisition cost and differs significantly for the various produc...